{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:02:03Z","timestamp":1790366523561,"version":"4.1.0"},"reference-count":132,"publisher":"Informa UK Limited","issue":"1","funder":[{"name":"T Yokota from Muscular Dystrophy Canada, the Friends of Garrett Cumming Research Fund"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2023,1,2]]},"DOI":"10.1080\/14712598.2022.2150543","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T19:16:52Z","timestamp":1669058212000},"page":"49-59","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":18,"title":["Biological and genetic therapies for the treatment of Duchenne muscular dystrophy"],"prefix":"10.1080","volume":"23","author":[{"given":"Harry","family":"Wilton-Clark","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Dentistry, Department of Medical Genetics, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Yokota","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Dentistry, Department of Medical Genetics, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01430-8"},{"key":"cit0002","volume-title":"Duchenne muscular dystrophy. StatPearls","author":"Venugopal V","year":"2021"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.bmb.a071623"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0631-3"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012910"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9103186"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2010.05.001"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1038\/ng0295-184"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00248-3"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.7400221"},{"issue":"5","key":"cit0011","volume":"13","author":"Mohammed F","year":"2018","journal-title":"PLoS One"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00131"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002337"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30024-3"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1991.00530160047012"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198906153202405"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20918"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddy171"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2001-2-5-reviews1015"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00750"},{"issue":"3","key":"cit0021","first-page":"179","volume":"26","author":"Yokota T","year":"2007","journal-title":"Acta Myologica Pacini Editore"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2019.55.10.3045038"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2020.56.8.3159186"},{"key":"cit0024","doi-asserted-by":"crossref","unstructured":"Baker DE. Eteplirsen Hosp Pharm. Thousand Oaks, CA: SAGE Publications Ltd; 2017. p. 302\u2013305.","DOI":"10.1310\/hpx5204-302"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01512-2"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.3390\/jpm8040041"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2016.28"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S97635"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009233"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27347"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.1264"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1016\/bs.mcb.2019.05.006"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.07.012"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21627"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201607199"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.3390\/jpm3030144"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.07.011"},{"issue":"1","key":"cit0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-016-0009-6","volume":"8","author":"le GC","year":"2017","journal-title":"Nat Commun"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2018.012"},{"key":"cit0040","unstructured":"A phase 3 study to evaluate the safety and efficacy of PF-06939926 for the treatment of duchenne muscular dystrophy - full text view - ClinicalTrials.gov [Internet]. [cited 2021 Dec 8]."},{"key":"cit0041","first-page":"9001","volume-title":"World Muscle Society Virtual Congress","author":"Zaidman C","year":"2021"},{"key":"cit0042","unstructured":"Microdystrophin gene transfer study in adolescents and children with dmd - full text view - ClinicalTrials.gov [Internet]. [cited 2021 Dec 8]."},{"key":"cit0043","unstructured":"A randomized, double-blind, placebo-controlled study of SRP-9001 for Duchenne Muscular Dystrophy (DMD) - full text view - ClinicalTrials.gov [Internet]. [cited 2021 Dec 8]."},{"key":"cit0044","unstructured":"FDA slaps clinical hold on solid bioscience DMD gene therapy program | BioSpace [Internet]. [cited 2021 Dec 26]."},{"key":"cit0045","unstructured":"FDA slaps second clinical hold on solid biosciences\u2019 DMD gene therapy due to adverse event | Biospace [Internet]. [cited 2021 Dec 26]."},{"key":"cit0046","unstructured":"Pfizer reports patient death in early-stage Duchenne gene therapy trial, halts enrollment | FierceBiotech [Internet]. [cited 2021 Dec 26]."},{"key":"cit0047","unstructured":"Sarepta therapeutics announces top-line results for part 1 of study 102 evaluating SRP-9001, its investigational gene therapy for the treatment of Duchenne muscular dystrophy | Sarepta Therapeutics, Inc. [Internet]. [cited 2021 Dec 8]."},{"key":"cit0048","unstructured":"Therapeutics\u2019 S. SRP-9001 shows sustained functional improvements in multiple studies of patients with Duchenne | Sarepta Therapeutics, Inc. [Internet]. [cited 2021 Dec 8]."},{"key":"cit0049","unstructured":"Pfizer to Open First U.S. Sites in phase 3 trial of investigational gene therapy for ambulatory patients with Duchenne muscular dystrophy | Pfizer [Internet]. [cited 2022 Aug 18]."},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-210-6_2"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.250570"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2017.11.007"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-306647"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1000228"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00670"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.658399"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2021.29182.bfs"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2020.29133.bfs"},{"issue":"12","key":"cit0059","first-page":"1074","volume":"54","author":"Takeshima Y","year":"2014","journal-title":"Clin Neurol"},{"issue":"11","key":"cit0060","first-page":"1253","volume":"63","author":"Shiozuka M","year":"2011","journal-title":"Brain and Nerve"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1177\/0883073810371129"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1177\/0883073810371129"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1177\/1756285610388693"},{"issue":"6","key":"cit0064","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.22024","volume":"67","author":"Malik V","year":"2010","journal-title":"Ann Neurol"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1111\/apa.14568"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2010.07.193"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31611-2"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0814-706"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2019-0171"},{"key":"cit0070","unstructured":"Long-term outcomes of ataluren in Duchenne muscular dystrophy - full text view - ClinicalTrials.gov [Internet]. [cited 2022 Aug 18]."},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-018-0024-7"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2020.01.007"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2020.08.031"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04252-2"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3437"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1038\/srep23549"},{"key":"cit0077","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79303-0"},{"key":"cit0078","first-page":"353","volume":"15","author":"Mengstie MA","year":"2021","journal-title":"Biologics"},{"issue":"3","key":"cit0079","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031832","volume":"23","author":"Erkut E","year":"2022","journal-title":"Int J Mol Sci"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1126\/science.1254445"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2017.02.007"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-081117-010451"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-021-00811-2"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.05.024"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.04.002"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03534-y"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0561-9"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1711-4"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02644-8"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg4910"},{"issue":"1","key":"cit0091","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20314-w","volume":"12","author":"Xu L","year":"2021","journal-title":"Nat Commun"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2018.09.002"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0323-0"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071608"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.37"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1101\/gr.231936.117"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.21037\/sci-2020-001"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1177\/1756285615586123"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.113086"},{"key":"cit0100","unstructured":"Allogeneic human umbilical cord mesenchymal stem cells for a single male patient with Duchenne Muscular Dystrophy (DMD) - full text view - ClinicalTrials.gov [Internet]. [cited 2022 Aug 8]."},{"key":"cit0101","unstructured":"Bone marrow-derived autologous stem cells for the treatment of Duchenne muscular dystrophy - full text view - ClinicalTrials.gov [Internet]. [cited 2022 Aug 8]."},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.21-0027"},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006950"},{"key":"cit0104","unstructured":"HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne) - full text view - ClinicalTrials.gov [Internet]. [cited 2022 Aug 8]."},{"key":"cit0105","unstructured":"A study of CAP-1002 in ambulatory and non-ambulatory patients with Duchenne muscular dystrophy - full text view - ClinicalTrials.gov [Internet]. [cited 2022 Aug 8]."},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006950"},{"key":"cit0107","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00012-5"},{"key":"cit0108","unstructured":"A study of CAP-1002 in ambulatory and non-ambulatory patients with duchenne muscular dystrophy (HOPE-3) - full text view - ClinicalTrials.gov [Internet]. [cited 2022 Aug 8]."},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-3806(99)00165-0"},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.1016\/j.fmre.2022.07.004"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.1.369"},{"key":"cit0112","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-800040-3.00004-2"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0594-0"},{"key":"cit0114","doi-asserted-by":"publisher","DOI":"10.1038\/4033"},{"key":"cit0115","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.642"},{"key":"cit0116","unstructured":"Proof of concept study to assess activity and safety of SMT C1100 (Ezutromid) in boys with Duchenne Muscular Dystrophy (DMD) - full text view - ClinicalTrials.gov [Internet]. [cited 2022 Aug 1]."},{"issue":"4","key":"cit0117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152840","volume":"11","author":"Ricotti V","year":"2016","journal-title":"PLoS One"},{"key":"cit0118","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.06.443"},{"key":"cit0119","unstructured":"Summit announces PhaseOut DMD did not meet primary [Internet]. [cited 2022 Aug 1]."},{"key":"cit0120","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2019.10.005"},{"key":"cit0121","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.01.005"},{"key":"cit0122","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.01.005"},{"key":"cit0123","unstructured":"Gene transfer clinical trial to deliver rAAVrh74.MCK.GALGT2 for Duchenne muscular dystrophy - full text view - ClinicalTrials.gov [Internet]. [cited 2022 Aug 2]."},{"key":"cit0124","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0205-4"},{"key":"cit0125","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17029-3"},{"key":"cit0126","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.05.020"},{"key":"cit0127","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3081"},{"key":"cit0128","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-017-0137-2"},{"issue":"12","key":"cit0129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081302","volume":"8","author":"Finkel RS","year":"2013","journal-title":"PLoS One"},{"key":"cit0130","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.07.012"},{"key":"cit0131","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1204638109"},{"key":"cit0132","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2112546119"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2022.2150543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T13:59:45Z","timestamp":1701439185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2022.2150543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":132,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,2]]}},"alternative-id":["10.1080\/14712598.2022.2150543"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2022.2150543","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-09-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}